New Momentum for Reform of Media Concentration Control
2 May 2025
Elanco Animal Health Incorporated today announced it had entered into an agreement with Bayer AG to acquire its animal health business in a transaction valued at $7.6 billion. The transaction will be financed by a 70% cash/30% equity combination.
Hengeler Mueller advises Elanco on the acquisition together with Paul, Weiss, Rifkind, Wharton & Garrison LLP (team is led by Tarun Stewart, New York). The Hengeler Mueller team is led by partners Christian Möller and Maximilian Schiessl (both M&A, Düsseldorf) and includes partners Hendrik Bockenheimer (Employment, Frankfurt), Wolfgang Kellenter (IP, Düsseldorf), Matthias Scheifele (Tax, München) and Dirk Uwer (Life Sciences / Public Law, Düsseldorf), counsel Markus Ernst (Tax, München), Benedikt Migdal (IP, Düsseldorf), Eckbert Müller (Employment, Frankfurt) and Ralf Willer (M&A, Berlin) as well as associates Oda Goetzke, Marc Seeger, Tianyuan Zhuang, Johannes Fütterer, Benedikt Statz, Alexander von Bernstorff (all Düsseldorf), Yenilee Ičagić (Berlin) (all M&A), Susanne Koch (Life Sciences / Public Law), Julia Fischer, Norman Koschmieder (both Public Law) (all Düsseldorf), Marius Mayer (Employment) and Sebastian Heinrichs (Tax) (both Frankfurt).
